ALTER Overzicht aandelen
Theradiag SA develops, manufactures, and markets in-vitro diagnostic products in France and internationally.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Theradiag SA Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | €1.26 |
| 52 Week Hoogtepunt | €2.39 |
| 52 Week Laag | €1.18 |
| Bèta | -0.27 |
| 11 maand verandering | -5.97% |
| 3 maanden verandering | -43.75% |
| 1 Jaar Verandering | -44.86% |
| 33 jaar verandering | -51.91% |
| 5 jaar verandering | 35.78% |
| Verandering sinds IPO | -77.74% |
Recent nieuws en updates
Slammed 26% Theradiag SA (EPA:ALTER) Screens Well Here But There Might Be A Catch
Oct 04
Theradiag (EPA:ALTER) Might Have The Makings Of A Multi-Bagger
Oct 03Rendement voor aandeelhouders
| ALTER | FR Medical Equipment | FR Markt | |
|---|---|---|---|
| 7D | -4.9% | -0.9% | -1.9% |
| 1Y | -44.9% | 23.7% | 1.9% |
Rendement versus industrie: ALTER underperformed the French Medical Equipment industry which returned 5.2% over the past year.
Rendement versus markt: ALTER underperformed the French Market which returned 12.7% over the past year.
Prijsvolatiliteit
| ALTER volatility | |
|---|---|
| ALTER Average Weekly Movement | 9.7% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.6% |
| 10% least volatile stocks in FR Market | 2.1% |
Stabiele aandelenkoers: ALTER's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: ALTER's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of French stocks.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1986 | 61 | Simon Daviere | www.theradiag.com |
Theradiag SA Samenvatting
| ALTER fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €16.44m |
| Inkomsten(TTM) | €421.92k |
| Inkomsten(TTM) | €13.51m |
39.0x
Koers/Winstverhouding1.2x
P/S-verhoudingIs ALTER overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| ALTER resultatenrekening (TTM) | |
|---|---|
| Inkomsten | €13.51m |
| Kosten van inkomsten | €7.24m |
| Brutowinst | €6.26m |
| Overige uitgaven | €5.84m |
| Inkomsten | €421.92k |
Laatst gerapporteerde inkomsten
Jun 30, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.032 |
| Brutomarge | 46.37% |
| Nettowinstmarge | 3.12% |
| Schuld/Eigen Vermogen Verhouding | 17.1% |
Hoe presteerde ALTER op de lange termijn?
Bekijk historische prestaties en vergelijking